Sun Pharma received USFDA approval for its drug to treat alopecia areata, an autoimmune disorder causing hair loss. The approval, granted on July 10, 2024, marks a significant milestone for Sun Pharma, allowing it to market the drug in the US. This drug offers a new treatment option for patients suffering from this condition and is expected to enhance the company’s product portfolio.
Sun Pharma’s Alopecia Areata Drug Gets USFDA Approval
